Emergent BioSolutions (EBS) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free EBS Stock Alerts $1.97 -0.21 (-9.63%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFDA approves Amneal's generic version of OTC Narcanmsn.com - April 24 at 2:20 PMEmergent BioSolutions (EBS) to Release Earnings on Wednesdaymarketbeat.com - April 24 at 6:45 AMEmergent BioSolutions (NYSE:EBS) Stock Price Passes Above 200-Day Moving Average of $2.25americanbankingnews.com - April 24 at 3:02 AMEmergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024globenewswire.com - April 22 at 8:05 AMInstitutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 16% drop adds to one-year lossesfinance.yahoo.com - April 17 at 3:19 PMShort Interest in Emergent BioSolutions Inc. (NYSE:EBS) Expands By 16.1%marketbeat.com - April 14 at 10:53 PMEmergent BioSolutions' (EBS) Buy Rating Reiterated at Benchmarkmarketbeat.com - April 11 at 9:17 AMAssenagon Asset Management S.A. Acquires 651,480 Shares of Emergent BioSolutions Inc. (NYSE:EBS)marketbeat.com - April 5 at 4:28 AMAquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executivefinance.yahoo.com - April 1 at 8:41 AMEmergent BioSolutions Inc. (NYSE:EBS) Short Interest Down 20.8% in Marchmarketbeat.com - March 30 at 2:16 PMEmergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisisglobenewswire.com - March 28 at 8:15 AMWhy this Maryland biotech furloughed 130 workers in Michiganbizjournals.com - March 27 at 6:50 PMEmergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facilityglobenewswire.com - March 25 at 8:05 AMEmergent BioSolutions Shares Drop on S&P Downgrademarketwatch.com - March 12 at 6:43 PMBenchmark gets more bullish on Emergent BioSolutions, upgrades sharesrealmoney.thestreet.com - March 7 at 6:33 PMEmergent BioSolutions upgraded to Buy at Benchmark after 'upbeat' Q4 reportrealmoney.thestreet.com - March 7 at 6:33 PMEmergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - March 7 at 6:33 PMEmergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 7 at 1:32 PMEmergent BioSolutions (NYSE:EBS) Lifted to Buy at Benchmarkmarketbeat.com - March 7 at 10:19 AMQ4 2023 Emergent BioSolutions Inc Earnings Callfinance.yahoo.com - March 7 at 8:31 AMEmergent BioSolutions (EBS) Q4 2023 Earnings Call Transcriptfool.com - March 7 at 2:11 AMEBS Stock Earnings: Emergent BioSolutions Misses EPS, Misses Revenue for Q4 2023investorplace.com - March 6 at 11:01 PMEmergent BioSolutions: Q4 Earnings Insightsbenzinga.com - March 6 at 9:09 PMEmergent BioSolutions Reports Fourth Quarter 2023 Financial Resultsglobenewswire.com - March 6 at 4:31 PMEmergent BioSolutions Reports Fourth Quarter 2023 Financial Resultsglobenewswire.com - March 6 at 4:31 PMEmergent Biosolutions Q4 2023 Earnings Previewmsn.com - March 6 at 4:09 PMEmergent BioSolutions (NYSE:EBS) Posts Earnings Results, Beats Expectations By $0.14 EPSmarketbeat.com - March 6 at 7:49 AMCharles Schwab Investment Management Inc. Has $5.31 Million Stock Holdings in Emergent BioSolutions Inc. (NYSE:EBS)marketbeat.com - March 5 at 4:30 AMEmergent BioSolutions's Earnings: A Previewbenzinga.com - March 4 at 5:42 PMEmergent BioSolutions (EBS) to Release Quarterly Earnings on Wednesdaymarketbeat.com - March 1 at 2:55 PMEmergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024globenewswire.com - February 29 at 7:00 AMNew CEO Appointment A Clear Positive For Emergent BioSolutionsseekingalpha.com - February 27 at 3:06 PMEmergent BioSolutions (EBS) Set to Announce Quarterly Earnings on Mondaymarketbeat.com - February 25 at 7:32 AMBiotech with Baltimore facility taps new CEObizjournals.com - February 21 at 6:59 PMWhy Is Emergent BioSolutions (EBS) Stock Up 70% Today?investorplace.com - February 21 at 4:07 PMWhy Is Emergent BioSolutions (EBS) Stock Up 70% Today?investorplace.com - February 21 at 3:24 PMTeladoc Health, Avinger among healthcare moversmsn.com - February 21 at 1:58 PMEmergent BioSolutions Gains 95% Following Announcement Of Joseph Papa As New CEOmarkets.businessinsider.com - February 21 at 1:58 PMEmergent names Joseph Papa as new CEOreuters.com - February 21 at 8:58 AMUPDATE 1-Emergent appoints former Bausch + Lomb CEO to head companyfinance.yahoo.com - February 21 at 8:58 AMEmergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEOglobenewswire.com - February 21 at 7:00 AMEmergent extends shelf life of opioid overdose reversal drug Narcanfinance.yahoo.com - January 17 at 3:45 PMEmergent BioSolutions Bags 5-year Contract To Supply BioThrax To U.S. Defense Dept.markets.businessinsider.com - January 11 at 2:03 PMEmergent BioSolutions wins $235.8M DoD contractmsn.com - January 11 at 8:56 AMEmergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defensefinance.yahoo.com - January 11 at 8:56 AMEmergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024finance.yahoo.com - January 9 at 10:47 AMEmergent BioSolutions: Q3 Numbers Leave Work To Be Doneseekingalpha.com - December 18 at 10:08 AMStockNews.com Upgrades Emergent BioSolutions (NYSE:EBS) to "Hold"marketbeat.com - December 12 at 10:19 PMEmergent Biosolutions (EBS) Reports Q3 Loss, Tops Revenue Estimatesfinance.yahoo.com - December 11 at 2:48 PMEmergent BioSolutions Stock (NYSE:EBS) Dividends: History, Yield and Datesbenzinga.com - December 3 at 2:20 PM Get Emergent BioSolutions News Delivered to You Automatically Sign up to receive the latest news and ratings for EBS and its competitors with MarketBeat's FREE daily newsletter. Email Address World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. EBS Media Mentions By Week EBS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EBS News Sentiment▼0.200.41▲Average Medical News Sentiment EBS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EBS Articles This Week▼42▲EBS Articles Average Week Get Emergent BioSolutions News Delivered to You Automatically Sign up to receive the latest news and ratings for EBS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BOLT News RGLS News FBIO News RIGL News VNDA News VSTM News XOMA News PDSB News IOBT News RNAC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:EBS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarningsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emergent BioSolutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
